Over 7 million Americans are living with Alzheimer’s, and the number is expected to nearly double in the decades ahead. Writing together in The Hill, Reps. Vern Buchanan (R-Fla.) and Paul Tonko (D-N.Y.) make the case that Congress has the tools to change that trajectory and no excuse left to wait. Read the full piece here →

From The Hill, by Reps. Vern Buchanan and Paul Tonko:

“Alzheimer’s disease doesn’t care about politics. It affects families in every state, congressional district and neighborhood across America.”

“For too long, diagnosing Alzheimer’s required lengthy referrals and invasive, expensive procedures. Today, simple blood-based biomarker tests can help identify the disease earlier and more conveniently than ever.”

“Earlier detection can give families more time to plan, pursue treatment and prepare for the challenges ahead.”

“Two hundred twenty-four of our House colleagues have co-sponsored our bill, a sign of momentum we should not squander. The time for waiting is over. We must act ASAP.”

Buchanan and Tonko’s piece in The Hill is a straightforward reminder that the ASAP Act has the votes, the science, and the public support behind it. What it needs now is action.

‍